| Literature DB >> 33539025 |
Johanna M Gostner1, Dietmar Fuchs2, Katharina Kurz3.
Abstract
The tryptophan catabolizing enzyme indoleamine 2,3-dioxygenase (IDO-1) has gained major attention due the immunoregulatory nature of this pathway. Both depletion of tryptophan concentrations as well as the accumulation of downstream metabolites are relevant for the mediation of the manifold consequences of increased tryptophan metabolism. Increased tryptophan catabolism is indicative for several chronic inflammatory disorders such as infections, autoimmune diseases or cancer. Low tryptophan availability is likely to be involved in the manifestation of a variety of comorbidities such as anemia, cachexia, depression and neurocognitive disturbances.Several nutrient sensing kinases are implicated in the downstream effects of dysregulated tryptophan metabolism. These include mechanisms that were conserved during evolution but have gained special features in multicellular eukaryotes, such as pathways regulated by eukaryotic translation initiation factor 2 (eIF-2)-alpha kinase (GCN2, also named general control nonderepressible 2 kinase), 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) and target of rapamycin (TOR).The interplay between IDO-1 and above-mentioned pathway seems to be highly context dependent. A better understanding of the crosstalk is necessary to support the search for druggable targets for the treatment of inflammatory and autoimmune disorders.Entities:
Keywords: 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK); Eukaryotic translation initiation factor 2 (eIF-2)-alpha kinase (GCN2); General control nonderepressible 2 kinase; Indoleamine 2,3-dioxygenase (IDO-1); Kynurenine; Nutrient sensing; Target of rapamycin (TOR); Tryptophan
Mesh:
Substances:
Year: 2021 PMID: 33539025 DOI: 10.1007/978-3-030-49844-3_16
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622